Primer Efficiency Assessment via Single Molecule Ct Value

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing primer efficiency in quantitative PCR are imprecise and labor-intensive, particularly when dealing with patient-specific primers used in monitoring minimal residual disease, as they require serial dilutions and regression analysis, which are prone to errors and variability.

Innovation Solution

A method that assesses primer efficiency by amplifying a single target DNA molecule and determining the cycle threshold (Ct) value, allowing for standardized comparison relative to reference primers, enabling rapid and accurate evaluation of primer pairs without the need for traditional Ct regression line modeling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional Ct regression line modeling is used to assess primer efficiency, then comprehensive data from serial dilutions is obtained, but the method becomes labor-intensive and prone to errors and variability

Engineering Contradiction:
Improveprimer efficiency assessment accuracyVSAvoidassessment method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts the essential information needed for primer efficiency assessment from the complex serial dilution process. Instead of analyzing multiple dilution points and performing regression analysis, the method isolates the critical measurement at a single concentration point (Ct value), eliminating unnecessary steps while retaining the core assessment capability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses a standardized reference amplification protocol that creates a reproducible template for assessing primer efficiency. By establishing a reference Ct value from a standardized amplification process, multiple primer sets can be evaluated against this fixed reference, replacing the need for complex individual regression analysis for each primer.

Inventive Principle:
Principle #26Copying

2Measurement precision

If serial dilutions and regression analysis are performed, then primer efficiency can be assessed, but the process requires significant labor and time

Engineering Contradiction:
Improveprimer efficiency assessment accuracyVSAvoidassessment speed
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention extracts only the essential measurement (Ct value at a single concentration) needed for primer efficiency assessment, discarding the time-consuming steps of preparing multiple serial dilutions and performing regression analysis. This extraction maintains assessment accuracy while dramatically reducing the time and labor required.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the assessment parameter from a complex regression analysis requiring multiple data points to a simple Ct value comparison at a single concentration point. This parameter change transforms a labor-intensive multi-step process into a rapid single-measurement assessment while maintaining the ability to evaluate primer efficiency.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If multiple primer sets are assessed using traditional methods, then individual efficiency data is obtained, but direct comparison between primer sets becomes difficult

Engineering Contradiction:
Improveprimer efficiency measurement accuracyVSAvoidprimer comparison ease
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The invention creates a universal reference framework that can be used to assess and compare multiple different primer sets against the same standardized reference. This universal approach allows direct comparison of primer efficiency across different targets and conditions, replacing the difficult task of comparing individual regression curves with simple Ct value comparisons against a common reference.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach provides a simpler, more reliable, and accurate method for assessing primer efficiency, reducing variability and labor, and enabling direct comparison of multiple primer sets, which is particularly beneficial in clinical and research settings where precise primer efficiency is crucial.

Implementation Method 1

amplifying the nucleic acid sample of step (i) in accordance with a standardised quantitative amplification protocol

Methodology Applied
Scientific EffectPCR amplification:

Implementation Method 2

The amplicons produced by said quantitative PCR are detected using a fluorescent dye or probe

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12163185B2Method of assessment
Publication Date: 2024.12.10 MONOQUANT PTY LTD
  • US12163185B2 patent drawing
  • US12163185B2 patent drawing

AI summary

Aspects of the present invention relate to methods of assessing the amplification efficiency of a primer especially the relative or absolute efficiency of a primer used in quantitative PCR amplification. Some of the methods described herein involve the assessment of primer efficiency relative to the Ct determined for a single target DNA molecule rather than Ct regression curve analysis of serially diluted samples. By assessing primer efficiency utilizing the approaches described herein, one can more efficiently select primers for the diagnosis and/or monitoring of disease conditions, analysis of specific gene regions of interest, the monitoring of disease conditions that are characterised by clonal lymphoid cell populations or disease conditions that are characterised by specific V(D)J recombination events including the detection of minimal or residual disease in leukaemia patients.